These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27468907)

  • 1. MILEPOST Multicenter Randomized Controlled Trial: 12-Month Weight Loss and Satiety Outcomes After pose
    Miller K; Turró R; Greve JW; Bakker CM; Buchwald JN; Espinós JC
    Obes Surg; 2017 Feb; 27(2):310-322. PubMed ID: 27468907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal Physiological Changes and Their Relationship to Weight Loss Following the POSE Procedure.
    Espinós JC; Turró R; Moragas G; Bronstone A; Buchwald JN; Mearin F; Mata A; Uchima H; Turró J; Delgado-Aros S
    Obes Surg; 2016 May; 26(5):1081-9. PubMed ID: 26337693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early experience with the Incisionless Operating Platform™ (IOP) for the treatment of obesity : the Primary Obesity Surgery Endolumenal (POSE) procedure.
    Espinós JC; Turró R; Mata A; Cruz M; da Costa M; Villa V; Buchwald JN; Turró J
    Obes Surg; 2013 Sep; 23(9):1375-83. PubMed ID: 23591548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Multicenter Study of the Primary Obesity Surgery Endoluminal (POSE 2.0) Procedure for Treatment of Obesity.
    Lopez Nava G; Arau RT; Asokkumar R; Maselli DB; Rapaka B; Matar R; Bautista I; Espinos Perez JC; Bilbao AM; Jaruvongvanich V; Vargas EJ; Storm AC; Neto MG; Abu Dayyeh BK
    Clin Gastroenterol Hepatol; 2023 Jan; 21(1):81-89.e4. PubMed ID: 35533995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Intragastric Balloon: Single Ambulatory Center Spanish Experience with 60 Patients in Endoscopic Weight Loss Management.
    Lopez-Nava G; Bautista-Castaño I; Jimenez-Baños A; Fernandez-Corbelle JP
    Obes Surg; 2015 Dec; 25(12):2263-7. PubMed ID: 25982804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intragastric Balloon Treatment for Obesity: Review of Recent Studies.
    Tate CM; Geliebter A
    Adv Ther; 2017 Aug; 34(8):1859-1875. PubMed ID: 28707286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary obesity surgery endoluminal (POSE) for the treatment of obesity: a systematic review and meta-analysis.
    Singh S; Bazarbashi AN; Khan A; Chowdhry M; Bilal M; de Moura DTH; Jirapinyo P; Thakkar S; Thompson CC
    Surg Endosc; 2022 Jan; 36(1):252-266. PubMed ID: 33523277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Primary Obesity Surgery Endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes.
    López-Nava G; Bautista-Castaño I; Jimenez A; de Grado T; Fernandez-Corbelle JP
    Surg Obes Relat Dis; 2015; 11(4):861-5. PubMed ID: 25701201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity.
    Ponce J; Woodman G; Swain J; Wilson E; English W; Ikramuddin S; Bour E; Edmundowicz S; Snyder B; Soto F; Sullivan S; Holcomb R; Lehmann J;
    Surg Obes Relat Dis; 2015; 11(4):874-81. PubMed ID: 25868829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reinforced POSE: the 18-Plication Solution.
    García RG; Velázquez JV
    Obes Surg; 2019 Nov; 29(11):3443-3447. PubMed ID: 31222496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: The ESSENTIAL trial.
    Sullivan S; Swain JM; Woodman G; Antonetti M; De La Cruz-Muñoz N; Jonnalagadda SS; Ujiki M; Ikramuddin S; Ponce J; Ryou M; Reynoso J; Chhabra R; Sorenson GB; Clarkston WK; Edmundowicz SA; Eagon JC; Mullady DK; Leslie D; Lavin TE; Thompson CC
    Obesity (Silver Spring); 2017 Feb; 25(2):294-301. PubMed ID: 28000425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates.
    Gersin KS; Rothstein RI; Rosenthal RJ; Stefanidis D; Deal SE; Kuwada TS; Laycock W; Adrales G; Vassiliou M; Szomstein S; Heller S; Joyce AM; Heiss F; Nepomnayshy D
    Gastrointest Endosc; 2010 May; 71(6):976-82. PubMed ID: 20304396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in self-reported eating patterns after laparoscopic sleeve gastrectomy: a pre-post analysis and comparison with conservatively treated patients with obesity.
    Figura A; Rose M; Ordemann J; Klapp BF; Ahnis A
    Surg Obes Relat Dis; 2017 Feb; 13(2):129-137. PubMed ID: 27692907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced reward-driven eating accounts for the impact of a mindfulness-based diet and exercise intervention on weight loss: Data from the SHINE randomized controlled trial.
    Mason AE; Epel ES; Aschbacher K; Lustig RH; Acree M; Kristeller J; Cohn M; Dallman M; Moran PJ; Bacchetti P; Laraia B; Hecht FM; Daubenmier J
    Appetite; 2016 May; 100():86-93. PubMed ID: 26867697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transoral gastric volume reduction as intervention for weight management: 12-month follow-up of TRIM trial.
    Brethauer SA; Chand B; Schauer PR; Thompson CC
    Surg Obes Relat Dis; 2012; 8(3):296-303. PubMed ID: 22178565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World Safety and Efficacy of Fluid-Filled Dual Intragastric Balloon for Weight Loss.
    Agnihotri A; Xie A; Bartalos C; Kushnir V; Sullivan S; Islam S; Islam E; Lamet M; Lamet A; Farboudmanesch R; Overholt BF; Altawil J; Early DS; Bennett M; Lowe A; Mullady DK; Adeyeri CS; El Zein M; Mishra P; Fayad L; Dunlap M; Oberbach A; Cheskin LJ; Kalloo AN; Khashab MA; Kumbhari V
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1081-1088.e1. PubMed ID: 29481969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a combined dietary, exercise and behavioral intervention and sympathetic system on body weight maintenance after intended weight loss: Results of a randomized controlled trial.
    Mai K; Brachs M; Leupelt V; Jumpertz-von Schwartzenberg R; Maurer L; Grüters-Kieslich A; Ernert A; Bobbert T; Krude H; Spranger J
    Metabolism; 2018 Jun; 83():60-67. PubMed ID: 29360493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Totally endoscopic implant to effect a gastric bypass: 12-month safety and efficacy outcomes.
    Sandler BJ; Biertho L; Anvari M; Rumbaut R; Morales-Garza LA; Torres-Barrera G; Marceau S; Hong D; Smith CD; Horgan S
    Surg Endosc; 2018 Nov; 32(11):4436-4442. PubMed ID: 29679149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial.
    Ikramuddin S; Blackstone RP; Brancatisano A; Toouli J; Shah SN; Wolfe BM; Fujioka K; Maher JW; Swain J; Que FG; Morton JM; Leslie DB; Brancatisano R; Kow L; O'Rourke RW; Deveney C; Takata M; Miller CJ; Knudson MB; Tweden KS; Shikora SA; Sarr MG; Billington CJ
    JAMA; 2014 Sep; 312(9):915-22. PubMed ID: 25182100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Previous weight loss as a predictor of weight loss outcomes after laparoscopic adjustable gastric banding.
    Sethi M; Beitner M; Magrath M; Schwack B; Kurian M; Fielding G; Ren-Fielding C
    Surg Endosc; 2016 May; 30(5):1771-7. PubMed ID: 26205561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.